News & Analysis on Clinical Trial Services & Contract Research And Development
New findings may have significant implications for the growing generics drugs industry, by challenging previous assumptions that all formulations of the same active pharmaceutical ingredient (API) are therapeutically equivalent.
Lanxess has said it will spin-off its Fine Chemicals operations into a separate business unit that is expected to become independent as of the second quarter next year.
Fisher Scientific International reported it's third quarter performance for 2005, which revealed profit had more than doubled as a result of improved sales and fewer acquisition related charges.
The GEA Group has completed an agreement to acquire Steris's freeze dryer (lyophiliser) product line, in a deal that aims to strengthen the group's Process Engineering Division in the Process Engineering Segment.
Proditec exhibited its new automatic visual tablet inspection system at the recent CPhI, designed to provide the first alternative to manual pharmaceutical tablet inspection for smaller laboratories.